4 is the total number of securities AH Equity Partners Bio II, L.L.C. has owned. The longest AH Equity Partners Bio II, L.L.C. has owned a single stock is 4 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| EQRx, Inc. | 4 | 4 | 41.49% | 55.25% | 61.93% | Q4 2021 | Q3 2022 | 4 | |
| NAUT | Nautilus Biotechnology... | 4 | 4 | 8.49% | 26.02% | 40.75% | Q4 2021 | Q3 2022 | 4 |
| Erasca, Inc. | 4 | 4 | 9.78% | 14.01% | 20.28% | Q4 2021 | Q3 2022 | 4 | |
| NVTA | InVitae Corporation | 4 | 4 | 2.00% | 4.72% | 9.30% | Q4 2021 | Q3 2022 | 4 |
Download | |||||||||
The securities at the top of the list , including EQRx, Inc., Nautilus Biotechnology, Inc., and Erasca, Inc., are the highest-conviction holdings of AH Equity Partners Bio II, L.L.C..
The conviction is calculated by counting the number of quarters a security has been reported by AH Equity Partners Bio II, L.L.C.. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that AH Equity Partners Bio II, L.L.C. owns currently or has owned in the past.